SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-09-023670
Filing Date
2009-11-25
Accepted
2009-11-25 15:23:23
Documents
1
Period of Report
2009-11-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 5097
  Complete submission text file 0001127602-09-023670.txt   6856
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 100 BROOKWOOD PLACE STE 410 BIRMINGHAM AL 35209
Business Address
FEATHERINGILL WILLIAM W (Reporting) CIK: 0000946066 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 091208260